APA

Peixoto P., Blomme A., Costanza B., Ronca R., Rezzola S., Palacios A. P., Schoysman L., Boutry S., Goffart N., Peulen O., Maris P., Di Valentin E., Hennequière V., Bianchi E., Henry A., Meunier P., Rogister B., Muller R. N., Delvenne P., Bellahcène A., Castronovo V. & Turtoi A. (20170830). HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies. : Oncogene.

Chicago

Peixoto P, Blomme A, Costanza B, Ronca R, Rezzola S, Palacios A P, Schoysman L, Boutry S, Goffart N, Peulen O, Maris P, Di Valentin E, Hennequière V, Bianchi E, Henry A, Meunier P, Rogister B, Muller R N, Delvenne P, Bellahcène A, Castronovo V and Turtoi A. 20170830. HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies. : Oncogene.

Harvard

Peixoto P., Blomme A., Costanza B., Ronca R., Rezzola S., Palacios A. P., Schoysman L., Boutry S., Goffart N., Peulen O., Maris P., Di Valentin E., Hennequière V., Bianchi E., Henry A., Meunier P., Rogister B., Muller R. N., Delvenne P., Bellahcène A., Castronovo V. and Turtoi A. (20170830). HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies. : Oncogene.

MLA

Peixoto P, Blomme A, Costanza B, Ronca R, Rezzola S, Palacios A P, Schoysman L, Boutry S, Goffart N, Peulen O, Maris P, Di Valentin E, Hennequière V, Bianchi E, Henry A, Meunier P, Rogister B, Muller R N, Delvenne P, Bellahcène A, Castronovo V and Turtoi A. HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies. : Oncogene. 20170830.